Opioid-blocking medication reduces brain's response to alcoholism cues
Wednesday, May 26, 2010 - 14:40
in Health & Medicine
Researchers at Harvard-affiliated McLean Hospital have produced the first evidence that the opioid blocker extended-release injectable naltrexone (XR-NTX) is able to reduce the brain's response to cues that may cause alcoholics to relapse.